Content of cytokine inflammatory markers in patients with chronic heart failure caused by cardiomyopathy

Content of cytokine inflammatory markers in patients with chronic heart failure caused by cardiomyopathy

The present article discusses the characteristics and significance of content violation of key pro-inflammatory cytokines IL-8, TNFa, MCP-1 and key anti-inflammatory cytokine IL-10 during pro-inflammatory stage in patients with chronic heart failure (CHF), determined by dilated cardiomyopathy (31 pa...

Full description

Bibliographic Details
Main Authors:	K. A. Khamitova, A. N. Chepurnaya, V. I. Nikulicheva, G. S. Safuanova
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2017-05-01
Series:	Acta Biomedica Scientifica
Subjects:	chronic heart failure dilated cardiomyopathy ischemic cardiomyopathy ischemic heart failure il-8 il-10 tnfa mcp-1
Online Access:	https://www.actabiomedica.ru/jour/article/view/389

Similar Items

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
by: Albert Topf, et al.
Published: (2021-11-01)

Comparative analysis of cardiomyopathy patients in the waiting list for heart transplantology treatment results depending on a disease etiology and a selected method of treatment
by: A. V. Gabriyelyan
Published: (2019-09-01)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
by: Wei Gao, et al.
Published: (2023-07-01)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
by: Danbo Lu, et al.
Published: (2019-06-01)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
by: Junhan Zhao, et al.
Published: (2020-11-01)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
by: Mei Zhou, et al.
Published: (2023-09-01)

Expression of interleukin 1, interleukin 27, and TNF α genes in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy: A case‐control study
by: Mahdiyar Iravani Saadi, et al.
Published: (2022-07-01)

Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study
by: Lulu Said Fundikira, et al.
Published: (2024-02-01)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
by: Carles Díez-López, et al.
Published: (2022-01-01)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
by: Konstantina Portokallidou, et al.
Published: (2023-02-01)

The Role of Cardiac T-Cadherin in the Indicating Heart Failure Severity of Patients with Non-Ischemic Dilated Cardiomyopathy
by: Vaida Baltrūnienė, et al.
Published: (2020-01-01)

Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy
by: Zhi-hua Zhang, et al.
Published: (2020-03-01)

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
by: Wei-Chieh Lee, et al.
Published: (2022-07-01)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
by: Thomas Beiert, et al.
Published: (2018-04-01)

Quantitative Profiling of Serum Carnitines Facilitates the Etiology Diagnosis and Prognosis Prediction in Heart Failure
by: Zhangwei Chen, et al.
Published: (2023-07-01)

Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing
by: Morales Maria-Aurora, et al.
Published: (2011-12-01)

Multimodal characterization of dilated cardiomyopathy: Geno‐ And Phenotyping of PrImary Cardiomyopathy (GrAPHIC)
by: Laura Keil, et al.
Published: (2024-02-01)

Sex Differences in Prognosis of Heart Failure Due to Ischemic and Nonischemic Cardiomyopathy
by: Antonio de Padua Mansur, et al.
Published: (2023-08-01)

Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy – Six months follow-up result
by: A. Momen, et al.
Published: (2016-11-01)

Relationships of Whole-Heart Myocardial Mechanics and Cardiac Morphometrics by Transthoracic Echocardiography with Main Prognostic Factors of Heart Failure in Non-Ischemic Dilated Cardiomyopathy
by: Karolina Mėlinytė-Ankudavičė, et al.
Published: (2023-03-01)

Elevated Serum Levels of IgG4 in Patients with Heart Failure with Reduced Ejection Fraction: A Prospective Controlled Study
by: Igor Volodarsky, et al.
Published: (2022-08-01)

The effectiveness of the cardiac resynchronization in a patient with ischemic cardiomyopathy
by: Diana R. Tudorașcu, et al.
Published: (2018-04-01)

Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin
by: Paula Lopez-Vazquez, et al.
Published: (2024-03-01)

Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Seyed Mahmood Nouraei, et al.
Published: (2007-07-01)

Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Ali Ghayemian, et al.
Published: (2007-08-01)

Endocardial Endothelial Dysfunction and Unknown Polymorphic Composite Accumulation in Heart Failure
by: Hsuan-Fu Kuo, et al.
Published: (2021-10-01)

Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
by: Lourdes Vicent, et al.
Published: (2023-04-01)

A case of dilated cardiomyopathy
by: Arvind Dambalkar
Published: (2017-01-01)

Modern View on the Dilated Cardiomyopathy
by: Yuzych I.
Published: (2014-06-01)

Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study)
by: Paulo Roberto Chizzola, et al.
Published: (2000-03-01)

Editorial: Metabolic Related Cardiomyopathy in Hyperglycemic Patients
by: Annalisa Capuano, et al.
Published: (2022-01-01)

Harmony in Chaos: Deciphering the Influence of Ischemic Cardiomyopathy and Non-Cardiac Comorbidities on Holter ECG Parameters in Chronic Heart Failure Patients: A Pilot Study
by: Ștefania-Teodora Duca, et al.
Published: (2024-02-01)

Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
by: Rachele Adorisio, et al.
Published: (2022-12-01)

Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results
by: Jiří Plášek, et al.
Published: (2024-01-01)

RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE
by: T. G. Kulikova, et al.
Published: (2015-09-01)

Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
by: Matteo Ponzoni, et al.
Published: (2023-02-01)

Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
by: Jianquan Zhao, et al.
Published: (2018-08-01)

Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results
by: Jiří Plášek, et al.
Published: (2024-04-01)

Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis
by: Xuehua Wang, et al.
Published: (2022-02-01)